Clinical trial · Observational
Cannabis Use and Outcomes in Black and White Patients With Cancer
NCT06037681CI-TRIAL-00096878C4CrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- Black cannabis users
- description
- African Americans that use cannabis at least once a week
- label
- Black non-cannabis users
- description
- African Americans that do not use cannabis for at least 3 months prior to enrollment
- label
- White cannabis users
- description
- Caucasians that use cannabis at least once a week
- label
- White non-cannabis users
- description
- Caucasians that do not use cannabis for at least 3 month prior to enrollment
Primary outcomes (3)
- measure
- Change from baseline of Cannabis use
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * 21 years or older * Black or white race * Solid tumor cancer within 3 years of enrollment * Cannabis use of at least once a week or non cannabis use for 3 months * experience pain but spend less than 50% in bed or chair * Prescribed or take opioid for at least 30 days for pain * Not pregnant or planning to become pregnant in the next 12 months * English speaking Exclusion Criteria: * Lymphoma, leukemia, and melanoma * CBD only use * Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol \[Marinol, Syndros\], Epidiolex) * race other than Black or White
References
Publications (0)
Data not yet available
No reference posted for this study.